Omda AS Expands Its Healthcare Portfolio with Strategic Acquisitions of CO-AX Accelerator alumni Dermicus AB, Aweria AB and Predicare AB
Omda AS, a leading provider of innovative healthcare solutions announces the acquisition of three groundbreaking companies, CO-AX Accelerator alumni Dermicus AB, Aweria AB and Predicare AB.
Publish date:2025-01-28
Gothenburg, Sweden – January 2025
Omda AS, a leading provider of innovative healthcare solutions announces the acquisition of three groundbreaking companies, CO-AX Accelerator alumni Dermicus AB, Aweria AB and Predicare AB. These strategic acquisitions underscore Omda’s commitment to enhancing telemedicine and emergency care solutions, setting new standards for healthcare delivery.
Dermicus AB: Revolutionizing Teledermatology and Telewound Care
Part of the CO-AX Accelerator program 2017-2024
Dermicus AB specializes in AI-powered telemedicine platforms designed for teledermatology and telewound care. Their mobile applications enable healthcare professionals to securely capture and share patient images for remote specialist review, streamlining the diagnostic process. Dermicus’ innovative solutions have significantly reduced dermatology waiting times in NHS regions from an average of 26 days to under one day, improving patient outcomes and accessibility to specialist care.
Aweria AB: Leading Emergency Department Information Systems
Part of the CO-AX Accelerator program 2017-2022
Aweria AB is renowned for its best-of-breed emergency department information system, which supports the entire acute care chain. From ambulance dispatch to ongoing care in emergency rooms, Aweria’s platform provides healthcare teams with real-time coordination tools and a comprehensive overview of critical patient information. This system enhances decision-making, improves efficiency, and ultimately elevates the quality of emergency care.
Strengthening Omda’s Position in Healthcare Innovation
The acquisitions of Dermicus AB and Aweria AB align with Omda’s vision of advancing medical imaging and emergency solutions. By integrating these companies’ expertise, Omda aims to deliver cutting-edge solutions that benefit healthcare providers and patients alike. These transactions are subject to FDI filing and approval, expected within 25 working days of signing.
Predicare AB: An easy-to-use decision support system to streamline patient handling
Part of the CO-AX Accelerator 2014-2015
Omda AS, previously announced the acquisition of Predicare, a provider of decision support software in the emergency care sector. Including Predicare in Omda’s portfolio will further strengthen the group´s position in the Nordic market for emergency software solutions.
Omda AS is a leading provider of innovative healthcare solutions, specializing in advanced medical imaging, telemedicine, and acute care systems. With a focus on enhancing patient outcomes and streamlining healthcare workflows, Omda continues to drive innovation across the global healthcare landscape.
“At CO-AX we are immensely proud to see these innovative contributions recognized by Omda AS. These companies have pushed the boundaries of healthcare technology—Dermicus revolutionizing teledermatology and telewound care, and Aweria transforming emergency department workflows. This acquisition not only validates their incredible achievements but also marks a significant step forward in advancing healthcare delivery on a global scale.” - Emma Hallenberg, Director of CO-AX Accelerator
The Largest Tech Startup Ecosystem for Health Innovation in the Nordics
CO-AX focus on tech innovations that address global health challenges and accelerate tech for health. We support startups at every stage—from entrepreneurship, pre incubation and tailored incubation to growth and global internationalisation and commercialisation.
Our portfolio showcases AI-driven, deep tech, and innovative startups that are transforming the way healthcare is delivered. These companies, from pre-seed to growth stages, are addressing global health challenges with cutting-edge solutions.
From early-stage innovators to Alumni already impacting the market, they represent the future of healthcare.
